GlassScriptPhysician profile
Matthew R Albert
NPI 1699729244
$514,277.94
in general payments reported to CMS, 2019-2025
24 companies · $65K in 2025
The $65K reported for 2025 was more than what 99% of Colon & Rectal Surgery providers received nationally (typical 2025 total: $317).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $111K · 2020: $37K · 2021: $45K · 2022: $72K · 2023: $103K · 2024: $81K · 2025: $65K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $158K · Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program: $51K · Travel and Lodging: $32K · Food and Beverage: $5,529 · Education: $2,500.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $158,022.80 |
| Compensation For Services Other Than Consulting, Including Serving As Faculty Or As A Speaker At A Venue Other Than A Continuing Education Program | $50,977.76 |
| Travel and Lodging | $32,317.41 |
| Food and Beverage | $5,528.71 |
| Education | $2,500.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Applied Medical Resources Corporation | $243,146.53 | 2019-2025 | Gelport Laparoscopic System, Gelpoint Path Transanal Access Platform |
| Stryker Corporation | $189,553.00 | 2019-2025 | Spy-Phi System, 1788, 1688 |
| Medtronic, INC. | $33,283.25 | 2021-2025 | Signia, Ligasure, Signet |
| Conmed Corporation | $20,247.76 | 2019-2024 | Airseal, System 2450 |
| Intuitive Surgical, INC. | $9,836.38 | 2019-2025 | Da Vinci Surgical System |
| Ethicon US, LLC | $8,450.86 | 2019-2024 | Echelon Endopath, Echelon Flex, Echelon; Endopath |
| Coopersurgical, INC. | $5,400.00 | 2019 | |
| Covidien LP | $1,162.14 | 2019 | |
| Baxter Healthcare | $974.66 | 2022-2023 | |
| Thd America, INC. | $734.91 | 2022-2025 | |
| Asensus Surgical, INC. | $408.64 | 2019 | |
| Integra Lifesciences Corporation | $338.46 | 2021-2022 | |
| Guard Medical INC. | $144.17 | 2023 | Npseal Medium, Npseal (5), Npseal Large |
| Medtronic USA, INC. | $106.43 | 2020 | |
| Distalmotion US | $106.37 | 2024 | Dexter L6 Robot |
Show all 22 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Smith+Nephew, INC. | $101.10 | 2023 | Renasys Go V2 Home, Renasys, Pico 14 |
| Coloplast Corp | $100.59 | 2023-2025 | Peristeen |
| Ethicon INC. | $80.15 | 2022 | |
| Lsi Solutions INC | $34.99 | 2019 | |
| Prescient Surgical | $32.70 | 2019 | |
| Dentsply Ih Ab | $23.59 | 2024 | Navina Rectal Catheter Set Regular |
| Abbvie INC. | $11.26 | 2021 |
2 companies reported research payments only; those appear in the research section below.
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
Research and ownership
$354,024.00 in ownership or investment interests, as reported to CMS. These are holdings a clinician or an immediate family member has in a company, not payments received.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Matthew Albert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.